Evidence map›Paper›PMID 38440708›Full record

ArticleIJU case reports2024

Trisomy 13 with retroiliac ureter diagnosed by assessment for recurrent febrile urinary tract infections.

Yosuke Morizawa, Mitsuru Tomizawa, Takuto Shimizu, Kenta Onishi, Shunta Hori, Daisuke Gotoh, Yasushi Nakai, Makito Miyake, Kazumasa Torimoto, Kiyohide Fujimoto

Open access · goldAbstract readCase Reports
In one paragraph

Article in IJU case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yosuke MorizawaDepartment of Urology Nara Medical University Kashihara Nara Japan.
Mitsuru TomizawaDepartment of Urology Nara Medical University Kashihara Nara Japan.
Takuto ShimizuDepartment of Urology Nara Medical University Kashihara Nara Japan.
Kenta OnishiDepartment of Urology Nara Medical University Kashihara Nara Japan.
Shunta HoriDepartment of Urology Nara Medical University Kashihara Nara Japan.ORCID https://orcid.org/0000-0001-9514-9964
Daisuke GotohDepartment of Urology Nara Medical University Kashihara Nara Japan.ORCID https://orcid.org/0000-0002-6056-3820
Yasushi NakaiDepartment of Urology Nara Medical University Kashihara Nara Japan.ORCID https://orcid.org/0000-0002-7579-0372
Makito MiyakeDepartment of Urology Nara Medical University Kashihara Nara Japan.ORCID https://orcid.org/0000-0001-9503-7356
Kazumasa TorimotoDepartment of Urology Nara Medical University Kashihara Nara Japan.
Kiyohide FujimotoDepartment of Urology Nara Medical University Kashihara Nara Japan.ORCID https://orcid.org/0000-0003-1507-2464
Nara Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Patients with trisomy 13 have multiple malformations, including urological anomalies, and severe cognitive and psychomotor disabilities. We conducted a ureteroureterostomy for a mid-ureteral stricture due to a retroiliac ureter in a patient with trisomy 13. Case presentation: A 6-month-old girl with trisomy 13 developed a urinary tract infection. Computed tomography for assessing recurrent urinary tract infection revealed a left mid-ureteral stricture due to the retroiliac ureter. At the age of 2, a ureteroureterostomy was performed. Two years after surgery, the urinary tract infection did not recur. Conclusion: Ureteroureterostomy is a safe procedure for children with trisomy 13 and multiple comorbidities. Surgical treatment should be considered for patients with trisomy 13 when agreed upon by the family and comorbidities are well-controlled.

Indexed as

hydronephrosismid‐ureteral strictureretroiliac uretertrisomy 13ureteroureterostomy

Identifiers

PMID38440708
PMCPMC10909142
OpenAlexW4391172833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.